ImmunoPrecise Antibodies Ltd. Files 6-K Report
Ticker: HYFT · Form: 6-K · Filed: Aug 26, 2024 · CIK: 1715925
Sentiment: neutral
Topics: sec-filing, 6-K, administrative
TL;DR
IPA files 6-K, confirms 20-F annual reports, based in Victoria.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on August 26, 2024, reporting a press release dated August 23, 2024. The filing is for the month of August 2024 and indicates the company will file annual reports under Form 20-F. The principal executive office is located in Victoria, British Columbia.
Why It Matters
This filing serves as an update for investors regarding the company's reporting status and administrative information.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) and does not contain new financial or operational information that would typically increase risk.
Key Numbers
- 001-39530 — SEC File Number (Identifies the company's filing history with the SEC)
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Filer of the report
- August 23, 2024 (date) — Date of the press release
- August 26, 2024 (date) — Filing date of the 6-K
- Victoria, British Columbia (location) — Location of principal executive office
- Kristin Taylor (person) — Signatory for the company
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public in its home country, has filed or is required to file with a stock exchange, or has distributed or is required to distribute to its security holders.
What specific document is being filed as part of this 6-K?
Exhibit 99.1, a Press Release dated August 23, 2024, is included with this 6-K filing.
Does ImmunoPrecise Antibodies Ltd. file annual reports as Form 20-F or 40-F?
The filing indicates that ImmunoPrecise Antibodies Ltd. files annual reports under cover of Form 20-F.
Where is ImmunoPrecise Antibodies Ltd.'s principal executive office located?
The principal executive office of ImmunoPrecise Antibodies Ltd. is located at 3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8.
Who signed this Form 6-K on behalf of ImmunoPrecise Antibodies Ltd.?
Kristin Taylor signed this Form 6-K on behalf of ImmunoPrecise Antibodies Ltd.
Filing Stats: 143 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-08-23 20:01:56
Filing Documents
- press_release_aug_23_202.htm (6-K) — 21KB
- ipa-ex99_1.htm (EX-99.1) — 11KB
- 0000950170-24-100308.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMUNOPRECISE ANTIBODIES LTD. Date: August 23, 2024 By: /s/ Kristin Taylor Name: Kristin Taylor Title: Chief Financial Officer